hVIVO (LON:HVO) Shares Up 9.5% – Here’s Why

hVIVO plc (LON:HVO)’s share price rose 9.5% on Friday . The stock traded as high as GBX 15.75 ($0.20) and last traded at GBX 15.61 ($0.20). Approximately 1,709,755 shares traded hands during trading, a decline of 48% from the average daily volume of 3,283,339 shares. The stock had previously closed at GBX 14.25 ($0.18).

hVIVO Stock Up 1.8 %

The firm has a market capitalization of £102.60 million, a price-to-earnings ratio of 5.98 and a beta of 0.97. The company has a debt-to-equity ratio of 33.86, a current ratio of 1.61 and a quick ratio of 1.16. The business has a fifty day moving average price of GBX 16.76 and a two-hundred day moving average price of GBX 21.44.

Insider Activity at hVIVO

In related news, insider Yamin Mo’ Khan sold 3,062,246 shares of the firm’s stock in a transaction on Thursday, March 6th. The shares were sold at an average price of GBX 17 ($0.22), for a total transaction of £520,581.82 ($671,285.39). 14.03% of the stock is owned by insiders.

About hVIVO

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.